Serge Rudaz (School of pharmaceutical sciences University of Geneva – Switzerland email: email@example.com) studied pharmacy in Switzerland, where he obtained his PhD in 1997. Later, he joined the National Research Center in Roma (Italy) for a post-doctoral position concerning the application of capillary electrophoresis (CE) hyphenated to mass spectrometry (MS) for chiral separation in biological fluids. From 1998 to 2011, he was master-assistant in Phytochemistry at the University of Lausanne then Maître d’Enseignement et de Recherche (MER), where he developed new strategies for untargeted metabolomic analyses. He was promoted Associate Professor in 2012 in the School of Pharmaceutical Sciences at the University of Geneva where he leads the biomedical and metabolomics analysis (BMA) group.
He has so far contributed to the field of analytical sciences with diverse activities including invited lectures, invited professorship in various Universities. He is a member of various scientific societies and scientific boards, such as the “Chimiométrie” congress series. Research group leader and member of the management Board of the Swiss Centre for Applied Human Toxicology (SCAHT) Foundation, Serge Rudaz is also president of the Competence Center in Chemical and Toxicological Analysis (ccCTA).
He published numerous scientific papers (>250) or book chapters (>10). Currently, he is interested in (UHP)LC and CE coupled to MS, advances in sample preparation, analysis of pharmaceuticals and counterfeits medicines, biological matrices, clinical and preclinical studies, including metabolism and toxicological analysis. Serge Rudaz is an expert in various chemometric approaches, including experimental design (DOE) validation and regulation (ISO17025) as well as multivariate data analysis (MVA) for metabolomics.